Table 1 Baseline clinical and demographic characteristics and initial therapies
Characteristics | GIK group | Control group |
|---|---|---|
Age, years ± SD | 60 ± 12 | 61 ± 12 |
Men | 351 (73.7) | 368 (79.3) |
Referred patients | 201 (42.3) | 180 (38.8) |
Body mass index | 26.7 ± 3.8 | 27.0 ± 4.0 |
Previous MI | 52 (10.9) | 53 (11.4) |
Previous PCI | 22 (4.7) | 24 (5.2) |
Previous CABG | 14 (2.9) | 12 (2.6) |
History of stroke | 17 (3.6) | 15 (3.2) |
Diabetes mellitus | 50 (10.5) | 49 (10.6) |
Hypertension | 134 (28.2) | 130 (28.0) |
Dyslipidaemia | 94 (19.7) | 95 (20.5) |
Currently smoker | 225 (47.3) | 237 (51.1) |
Positive family history | 195 (41.0) | 179 (38.6) |
Time to admission, min (IQR)* | 150 (100–215) | 150 (105–234) |
Door to balloon time, min (IQR) | 45 (31–64) | 48 (34–69) |
Killip class 1 | 426 (89.5) | 430 (92.7) |
Killip class 2 | 24 (5.0) | 14 (3.0) |
Killip class 3 | 14 (2.9) | 14 (3.0) |
Killip class 4 | 12 (2.5) | 6 (1.3) |
Anterior MI | 250 (52.9) | 224 (49.1) |
Multi-vessel disease | 249 (52.3) | 242 (52.2) |
PCI | 436 (91.6) | 424 (91.4) |
Stent ** | 255 (58.5) | 236 (55.7) |
GP IIb/IIIa receptor blocker ** | 96 (22.1) | 109 (25.7) |
In-hospital CABG | 19 (4.0) | 19 (4.1) |
TIMI 3 flow | 459 (96.4) | 435 (93.8) |
Successful reperfusion‡ | 394 (82.8) | 384 (82.8) |
Intra-aortic balloon pump | 45 (9.5) | 42 (9.1) |
Mechanical ventilation | 12 (2.5) | 4 (0.9) |